ResMed Inc. (LON:0KW4)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 27.43B |
| Revenue (ttm) | 3.91B |
| Net Income (ttm) | 1.07B |
| Shares Out | n/a |
| EPS (ttm) | 7.27 |
| PE Ratio | 25.64 |
| Forward PE | 22.52 |
| Dividend | 1.72 (0.68%) |
| Ex-Dividend Date | Nov 13, 2025 |
| Volume | 954 |
| Average Volume | 406 |
| Open | 252.22 |
| Previous Close | 248.93 |
| Day's Range | 250.80 - 252.92 |
| 52-Week Range | 199.71 - 297.98 |
| Beta | 0.88 |
| RSI | 58.97 |
| Earnings Date | Jan 29, 2026 |
About ResMed
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring... [Read more]
Financial Performance
In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.
Financial numbers in USD Financial StatementsNews
Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now?
Boston Scientific edges out Resmed as WATCHMAN momentum, EP gains and acquisitions fuel stronger recent price performance in a growing medical device market.
Buy These 5 Low-Leverage Stocks Amid a Reversal of Santa Claus Rally
A stalled Santa Claus rally has investors rotating to stability, spotlighting low-leverage names like Resmed that may hold up better amid tech-led volatility.
3 Stocks Likely to Gain From Rising HSA Contribution & Medicare Premium
Rising HSA limits and higher Medicare premiums in 2026 could lift demand for chronic care devices from DexCom, ResMed and Masimo.
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Have an RMD Coming Your Way This December? 3 Ways to Make the Most of It.
It's important that you put that money to good use.
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present ...
Stifel Lowers Price Target for ResMed (RMD) to $260, Maintains Hold Rating | RMD Stock News
Stifel Lowers Price Target for ResMed (RMD) to $260, Maintains Hold Rating | RMD Stock News
Tandem upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026
ResMed (RMD) Downgraded by Baird, Price Target Lowered to $275 | RMD Stock News
ResMed (RMD) Downgraded by Baird, Price Target Lowered to $275 | RMD Stock News
ResMed (RMD) Shares Cross Above 200 DMA
In trading on Monday, shares of ResMed Inc. (Symbol: RMD) crossed above their 200 day moving average of $253.22, changing hands as high as $255.83 per share. ResMed Inc. shares are currently trading u...
RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort
Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.
Top 50 High-Quality Dividend Growth Stocks For December 2025
I track a custom universe of 50 high-quality dividend growth stocks to identify timely, attractive investment opportunities based on valuation and forward return potential. 28 of these stocks currentl...
Resmed Gets FDA Clearance For Personalized Therapy Comfort Settings; To Be Marketed As Smart Comfort
(RTTNews) - Resmed (RMD, RMD.AX), Monday announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed as Smart Comfort.
Resmed (RMD) Achieves FDA Clearance for Smart Comfort Device
Resmed (RMD) Achieves FDA Clearance for Smart Comfort Device
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has rece...
Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed
(RTTNews) - Several healthcare and biotech names posted notable gains in Thursday's after-hours session, driven by clinical updates, earnings results, and regulatory developments.
Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD)
Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD)
Should You Continue to Hold RMD Stock in Your Portfolio?
Resmed sees strong mask sales, strategic acquisitions and international expansion despite macro and competitive challenges.
Insider Sell Alert: Brett Sandercock Sells Shares of ResMed Inc (RMD)
Insider Sell Alert: Brett Sandercock Sells Shares of ResMed Inc (RMD)
ResMed (RMD) Dropped from Goldman Sachs' APAC Conviction List
ResMed (RMD) Dropped from Goldman Sachs' APAC Conviction List
PETER FARRELL At ResMed Acquires Stock Options Worth $7K
A substantial insider move unfolded on November 26, as FARRELL, Board Member at ResMed (NYSE: RMD), reported the acquisition of stock options for 1,331 shares in an SEC filing. What Happened: Disclos...
Michael J Farrell Makes Strategic Play: Invests $179K In ResMed Stock Options
Michael J Farrell , Chairman and CEO at ResMed (NYSE: RMD), reported acquisition of company stock options on November 26, according to a new SEC filing. What Happened: Revealed in a Form 4 filing on ...
Insider Sell: Witte De Sells 2,055 Shares of ResMed Inc (RMD)
Insider Sell: Witte De Sells 2,055 Shares of ResMed Inc (RMD)
IDEXX Laboratories Vs ResMed: Which Stock Could Rally?
IDEXX Laboratories' (IDXX) recent jump has investors questioning whether it's still the best bet—or if a stronger opportunity exists elsewhere. A closer look at its key competitor suggests there may b...